Fifth Third Bancorp’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $24.8K | Buy |
76
+6
| +9% | +$1.96K | ﹤0.01% | 1693 |
|
|
2025
Q1 | $18.9K | Buy |
70
+5
| +8% | +$1.35K | ﹤0.01% | 1771 |
|
|
2024
Q4 | $15.3K | Buy |
65
+43
| +195% | +$10.1K | ﹤0.01% | 1854 |
|
|
2024
Q3 | $6.05K | Buy |
22
+17
| +340% | +$4.68K | ﹤0.01% | 2138 |
|
|
2024
Q2 | $1.22K | Sell |
5
-3
| -38% | -$729 | ﹤0.01% | 2316 |
|
|
2024
Q1 | $1.2K | Buy |
8
+4
| +100% | +$598 | ﹤0.01% | 2256 |
|
|
2023
Q4 | $766 | Hold |
4
| – | – | ﹤0.01% | 2424 |
|
|
2023
Q3 | $708 | Hold |
4
| – | – | ﹤0.01% | 2485 |
|
|
2023
Q2 | $760 | Hold |
4
| – | – | ﹤0.01% | 2532 |
|
|
2023
Q1 | $801 | Sell |
4
-17
| -81% | -$3.4K | ﹤0.01% | 2663 |
|
|
2022
Q4 | $4.99K | Buy |
21
+3
| +17% | +$713 | ﹤0.01% | 2207 |
|
|
2022
Q3 | $4K | Buy |
18
+4
| +29% | +$889 | ﹤0.01% | 2215 |
|
|
2022
Q2 | $2K | Buy |
14
+4
| +40% | +$571 | ﹤0.01% | 2408 |
|
|
2022
Q1 | $2K | Buy |
+10
| New | +$2K | ﹤0.01% | 2498 |
|
|
2021
Q3 | – | Sell |
-2,341
| Closed | -$397K | – | 2635 |
|
|
2021
Q2 | $397K | Hold |
2,341
| – | – | ﹤0.01% | 769 |
|
|
2021
Q1 | $331K | Buy |
+2,341
| New | +$331K | ﹤0.01% | 792 |
|
|
2015
Q4 | – | Sell |
-14
| Closed | -$1K | – | 2727 |
|
|
2015
Q3 | $1K | Buy |
+14
| New | +$1K | ﹤0.01% | 2713 |
|
|
2014
Q4 | – | Sell |
-2,380
| Closed | -$186K | – | 2359 |
|
|
2014
Q3 | $186K | Buy |
2,380
+299
| +14% | +$23.4K | ﹤0.01% | 977 |
|
|
2014
Q2 | $131K | Buy |
2,081
+330
| +19% | +$20.8K | ﹤0.01% | 1089 |
|
|
2014
Q1 | $118K | Buy |
1,751
+1,257
| +254% | +$84.7K | ﹤0.01% | 1123 |
|
|
2013
Q4 | $32K | Buy |
+494
| New | +$32K | ﹤0.01% | 1504 |
|